Pulse Biosciences Inc (PLSE) — Cash Flow-to-Debt Ratio
Pulse Biosciences Inc (PLSE) has a Cash Flow-to-Debt Ratio of -0.95x as of December 2025, meaning its operating cash flow of $-14.76 Million could theoretically repay -1% of its total liabilities ($15.46 Million) in one year. See Pulse Biosciences Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pulse Biosciences Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Pulse Biosciences Inc across 12 annual periods. Also explore net asset growth rate of Pulse Biosciences Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pulse Biosciences Inc (2014–2025)
Year-by-year debt coverage analysis for Pulse Biosciences Inc. For market capitalisation and broader financial context, see Pulse Biosciences Inc (PLSE) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.50x | $-54.12 Million | $15.46 Million | ▼ -69.5% |
| 2024 | -2.07x | $-36.34 Million | $17.60 Million | ▲ +7.5% |
| 2023 | -2.23x | $-33.04 Million | $14.79 Million | ▼ -280.6% |
| 2022 | -0.59x | $-47.01 Million | $80.12 Million | ▲ +79.9% |
| 2021 | -2.91x | $-54.10 Million | $18.56 Million | ▼ -51.6% |
| 2020 | -1.92x | $-35.37 Million | $18.40 Million | ▲ +37.1% |
| 2019 | -3.06x | $-34.19 Million | $11.18 Million | ▲ +44.9% |
| 2018 | -5.55x | $-23.90 Million | $4.31 Million | ▼ -91.5% |
| 2017 | -2.90x | $-11.09 Million | $3.83 Million | ▲ +63.4% |
| 2016 | -7.92x | $-8.05 Million | $1.02 Million | ▼ -57.6% |
| 2015 | -5.03x | $-3.32 Million | $659.76K | ▼ -5188.7% |
| 2014 | -0.10x | $-173.14K | $1.82 Million | — |